AVIEW LCS+

Coreline Soft

The LCS+ software from Coreline Soft provides information on the 3 main lung diseases: lung cancer, COPD and coronary artery calcification based on a Low Dose, non-enhanced, non-gated CT-scan
Product specifications Information source: Vendor
Last updated: Jan. 21, 2022
General
Product name AVIEW LCS+
Company Coreline Soft
Subspeciality Chest
Modality CT
Disease targeted Lung Cancer, COPD, coronary artery calcifications
Key-features Nodule detection, nodule classification, nodule volume quantification, VDT, Lung-RADS score, Emphysema score, CAC-score
Suggested use During: perception aid (prompting all abnormalities/results/heatmaps), report suggestion
Data characteristics
Population All adult non-enhanced chest CTs, including screening population
Input Chest CT of different vendors. Non-enhanced, non-gated
Input format DICOM
Output Emphysema index (LAA), Coronary calcification score per branch, CAD, Lung-RADS, VDT, solid/non-solid
Output format SR, PDF, copy-paste to report, Encapsulated DICOM PDF
Technology
Integration Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Stand-alone third party application, Stand-alone webbased
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution
Trigger for analysis Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time 1 - 10 minutes
Certification
CE
Certified, Class IIa , MDD
FDA
 510(k) cleared, Class II
Market presence
On market since 11-2017
Distribution channels RMS Medical Devices
Countries present (clinical, non-research use) 10+
Paying clinical customers (institutes)
Research/test users (institutes) 10+
Pricing
Pricing model Subscription, One-off payment
Based on Number of users, Number of installations
Evidence
Peer reviewed papers on performance

  • Outstanding negative prediction performance of solid pulmonary nodule volume AI for ultra-LDCT baseline lung cancer screening risk stratification (read)

  • Variability in interpretation of low-dose chest CT using computerized assessment in a nationwide lung cancer screening program: comparison of prospective reading at individual institutions and retrospective central reading (read)

  • Implementation of the cloud-based computerized interpretation system in a nationwide lung cancer screening with low-dose CT: comparison with the conventional reading system (read)
Non-peer reviewed papers on performance
Other relevant papers